Abstract:Carbamazepine (CBZ), a Biopharmaceutics Classification System (BCS) class II drug, is widely-used as a first line antiepileptic drug. Numbers of cocrystals have reported to regulate its poor solubility. However, the solubility behaviors are rarely discussed on theoretical calculations and phase solubility diagrams. In this study, two new drug-drug cocrystals (DDC) of CBZ with emodin (EMO, 1: 1) and paeonol (PAE, 1: 1) as conformers, which offer the advantages of synergetic therapy and patient compliance are reported for the first time. The solubilities in water and in pH = 1.2, 6.8 buffer solutions, demonstrating that the rank order is as follows: CBZ-PAE > CBZ > CBZ-EMO. CBZ-PAE presents the biggest solubility at 0.563 ± 0.003 mmoL/L of in water among all the investigated samples. The solubilities of all the starting materials and cocrystals in six pure organic solvents such as methanol, ethanol, 2-propanol, acetone, acetonitrile, ethyl acetate were investigated to discuss the phase solubility diagrams. The results indicate that experimental solubilities are consistent with the theoretical solubilities on consideration of solubility product (Ksp) and solution binding constant (K11) together. The enthalpy differences between cocrystal and its coformer are calculated through the Perdew-Burke-Ernzerhof (PBE) functional with the projector augmented wave (PAW) pseudopotentials. CBZ-EMO presents the lowest enthalpy (−0.38 kcal/mol) with a highly unfavorable solvation energy (2.42 kcal/mol), resulting in unfavorable in an aqueous environment. Overall, the phase solubility diagrams and theoretical calculations support the solubility regulations on DDCs of CBZ.

Stability, Solubility and Thermodynamic Properties of Dimorphs of Furosemide-4,4′-bipyridine Cocrystals in Organic Solvents

Furosemide Cocrystals: Structures, Hydrogen Bonding, and Implications for Properties

Thermodynamic Investigation of Carbamazepine-Saccharin Co-Crystal Polymorphs

Solubility and Solution Thermodynamics of Flufenamic Acid Polymorphs in Two Binary Solvents

Molecular structures, solubility and pharmaceutical reactivities of flurbiprofen-based co-crystals: A DFT study

Evidence for solid- and liquid-state interactions in a furosemide-polyvinylpyrrolidone solid dispersion

Preformulation Study for Seven Solid Forms of Dotinurad

Synthesis and structural investigation of salts of 2-amino-3-methylpyridine with carboxylic acid derivatives: an experimental and theoretical study

Solubilities of Sulfuryl Fluoride in Propylene Carbonate, Tributyl Phosphate and N-methylpyrrolidone

Studying thermodynamic aspects of sublimation, solubility and solvation processes and crystal structure analysis of some sulfonamides

Phase transition and solubility of levofloxacin crystal forms: anhydrates versus hydrates

Cocrystals of carbamazepine: Structure, mechanical properties, fluorescence properties, solubility and dissolution rate

Dissolution Profiles of Carbamazepine Cocrystals with Cis–Trans Isomeric Coformers

Measurement and Correlation of Solubility and Thermodynamic Properties of Fluoxetine Hydrochloride in 15 Pure Solvents and a Methanol + Water Binary Solvent System

Furosemide/Non-Steroidal Anti-Inflammatory Drug–Drug Pharmaceutical Solids: Novel Opportunities in Drug Formulation

Formation Thermodynamics of Carbamazepine with Benzamide, Para-Hydroxybenzamide and Isonicotinamide Cocrystals: Experimental and Theoretical Study

Physical-chemical properties of furosemide nanocrystals developed using rotation revolution mixer

Polymorphism Observed in Dapsone–flavone Cocrystals That Present Pronounced Differences in Solubility and Stability

Amorphization of different furosemide polymorphic forms during ball milling: Tracking solid-to-solid phase transformations

Solvent Effect on Molecular Conformational Evolution and Polymorphic Manipulation of Cimetidine

Phase solubility investigation and theoretical calculations on drug-drug cocrystals of carbamazepine with Emodin, Paeonol